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Abstract: Routine biomarker results from hospital laboratory information systems, covering
hospitals and general practitioners, in Denmark are available to researchers through access to
the regional Clinical Laboratory Information System Research Database at Aarhus
University and the nationwide Register of Laboratory Results for Research. This review
describes these two data sources. The laboratory databases have different geographical and
temporal coverage. They both include individual-level biomarker results that are electro-
nically transferred from laboratory information systems. The biomarker results can be linked
to all other Danish registries at the individual level, using the unique identifier, the CPR
number. The databases include variables such as the CPR number, date and time (hour
and minute) of sampling, NPU code, and name of the biomarker, identification code for the
laboratory and the requisitioner, the test result with the corresponding unit, and the lower and
upper reference limits. Access to the two databases differs since they are hosted by two
different institutions. Data cannot be transferred outside Denmark, and direct access is
provided only to Danish institutions. It is concluded that access to data on routine biomarkers
expands the detailed biological and clinical information available on patients in the Danish
healthcare system. The full potential is enabled through linkage to other Danish healthcare
registries.
Keywords: biomarkers, database, data resource, laboratory information systems
Data Resource Basics
Danish Healthcare Registries
Denmark has a large network of population-based healthcare registries.1 Several
supplementary issues of international medical journals have been devoted to
describe these registries to facilitate their use in research.2,3 The registries contain
data on the Danish population of approximately 5.8 millions inhabitants and include
data on healthcare contacts, hospital diagnoses, redeemed prescriptions, childbirths,
causes of death, and a wide variety of other information. The Civil Registration
System and the healthcare system in Denmark have been described in detail
elsewhere.1,4 In short, all Danish residents are assigned a unique 10-digit personal
identification number, the CPR number, upon birth or immigration. The CPR
number serves as the key identifier in the nationwide registration of personal
data, including contacts with the healthcare system. The CPR number also allows
Statistics Denmark (www.dst.dk/en) to produce updated population statistics at the
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individual level on a variety of different topics, including,
but not limited to demographics, income, education, and
healthcare use.
The Danish healthcare system provides free healthcare
to all residents at general practices and hospitals through
a tax-paid system. This allows for long-term and virtually
complete follow-up at the individual level across the dif-
ferent sources of healthcare data.
This review provides an overview of the two Danish
healthcare research databases that collect routine individual-
level biomarker data from general practitioners and hospital
encounters: the regional Clinical Laboratory Information
System Research (LABKA) Database at Aarhus University5
and the nationwide Register of Laboratory Results for
Research (RLRR).6 These specific databases enable research-
ers to obtain very detailed and comprehensive biological
information for research purposes.
Hospital laboratories are an integrated part of the public
hospital system. Private medical laboratories play a minor
role for routine biomarker analyses in Denmark, as they
only provide very limited number of the test results and
mainly for low throughput and highly specialized biomar-
kers, eg lactate dehydrogenase isoenzymes and metabolic
intermediates.
Routine Clinical Biomarkers in the Danish
Healthcare System
Biomarkers are used in everyday clinical workstream in
general practice and in the hospital setting for diagnosis,
screening, monitoring, assessment of prognosis, and evalua-
tion of treatment effects and safety. Upon physician request,
biological samples (blood, urine, cerebrospinal fluid, and
other body fluids) undergo biomarker analysis in public
hospital laboratories, and thus biomarker data are recorded
in the registries as a by-product of healthcare provision. The
biomarker results are registered in the electronic laboratory
information systems using the International System of
Nomenclature, Properties, and Units (the NPU system).7
Only very few biomarker results are recorded by non-
electronic methods including some of the highly specialized
biomarkers. The NPU system, an international standardised
terminology for reporting on laboratory results, was estab-
lished in 1960 by the International Union of Pure and
Applied Chemistry (IUPAC) and the International
Federation of Clinical Chemistry and Laboratory Medicine
(IFCC). The NPU system is equivalent to the Logical
Observation Identifiers Names and Codes (LOINC) used in
other parts of the world.8 The organization of the NPU
system complies with recommendations from these two lead-
ing international laboratory organizations. In Denmark, the
NPU systemwas implemented in 2001, but some biomarkers
do not comply with the NPU system and are coded using
national or local codes. The results for these biomarkers are
also included in the laboratory information systems.
The Danish hospital laboratories use the laboratory
information system for managing data on requisitions,
specimen handling, transportation, and biomarker results.
The LABKA database and the RLRR described in this
review mainly cover routine biomarker results including
some results for therapeutic drug monitoring and genetic
tests. Clinical microbiology and pathology are not
included in the two research databases, but are covered
in other databases.9–11
Specifications for the LABKA database and the RLRR
are described in detail below and in Table 1. The two
databases show some degree of overlap, since some geo-
graphical regions of Denmark are represented in both
databases.
The LABKA database5 is named after a specific labora-
tory information system software called LABKA.
A previous publication has described the features of the
first version of the laboratory information system called
LABKA as a real-time computer system for handling and
transfer of data to and from the hospital laboratory.11 The
LABKA database covers two (Northern and Central Danish
Regions) of the five geographical regions in Denmark.
These two regions currently have a combined population
of 1.9 million inhabitants.12 Data are considered complete
for the geographical regions since 2005, but data from the
late 1990s are available for some smaller geographical areas
of the Northern and Central Danish Regions. The LABKA
database holds biomarker results on more than 2.4 million
individual patients dispersed over more than 6,000 different
biomarker codes, coding for more than 1,700 different
biomarkers. As an example, more than 8 million measure-
ments of haemoglobin were performed on more than
1 million patients between 1999 and 2007. Further details
are found in an earlier publication.5 It is hosted by the
Department of Clinical Epidemiology, Aarhus University
Hospital, Denmark.
The RLRR contains nationwide biomarker data from
the Danish population of 5.8 million inhabitants.13 The
RLRR has varying temporal coverage as data collection
started at different time points for the five Danish regions
Arendt et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
Clinical Epidemiology 2020:12470
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(Table 1). The database became available to researchers in
2018 and is hosted by the Danish Health Data Authority.6
Data Collection
Content
The main variables contained in the two data sources are
broadly comparable. They include the CPR number, date
and time (hour and minute) of sampling, the NPU (or
Danish modified) code or local code, identification codes
of the laboratory and the requisitioner, the biomarker result,
unit (eg mmol/L or ng/L), and lower and upper reference
limits. The LABKA database also records the name of the
biomarker and most text-written non-numeric results. The
RLRR currently includes only the following text-written
results: “positive”, “negative”, “ABO blood type”, and
“rhesus blood type”. Hence, other text results are missing
from the RLRR. The overall proportion of missing data has
not been assessed, but the electronic data transfer should
ensure a limited proportion of missing data.
Requisition of biomarkers through an electronic clin-
ical user interface is essentially the same in hospitals,
general practices, and private specialist clinics. Each
requisition is transferred from the clinical user interface
to the laboratory information system. Most general
practitioners handle sampling (eg venepuncture and urine
or stool collection) and then send the samples by postal
mail, courier services, or other transportation systems. At
hospitals, laboratory technicians perform most venepunc-
tures, and physicians or nursing staff collect other samples
(eg urine, cerebrospinal fluid).
Point-of-care testing (POCT) equipment enables rapid
bedside biomarker analysis results. POCT analyses are
distinguished from analyses performed at hospital labora-
tories by separate NPU codes. Recording of POCT bio-
marker results in the databases requires online access to
the laboratory information system, which is inherent in
most POCT equipment used in hospitals. However, results
of POCT tests performed by general practitioners or spe-
cialist clinics are not recorded in the laboratory informa-
tion system.
The two laboratory databases are updated with different
time intervals. The LABKA database is updated irregularly,
at intervals of one to two years. The RLRR database is
updated on a monthly basis from a national laboratory data-
bank. This national databank transfers laboratory results both
to a secured website for access by health professionals14 and
to a personal electronic medical file with unique personal
access for individual Danish residents.15
The pattern of test results follows clinical practice.
Figure 1 provides an overview of the 20 most frequent
biomarker analyses performed in the Central Denmark
region from 1 January 2008 to 31 December 2018, includ-
ing the total number of tests and the number of unique
patients with at least one result for a given biomarker. As
expected, the most commonly recorded results included
basic haematological and infection tests, lipid and HbA1c
levels, and measurements of liver, kidney and thyroid
function. The data we present from the laboratory infor-
mation system of Central Denmark is likely representative
of Denmark as a whole, as Danish registries show a high
degree of homogeneity for health care utilization across
the five Danish regions.16
Data Quality
The quality of biomarker results in the Laboratory
Information Systems Databases is generally high. Most hos-
pital laboratories in Denmark are accredited in accordance
with the standards for medical laboratory testing specified by
the International Organization for Standardization (ISO
15189).17 As a result, quality management systems in
Danish laboratories comply with international standards,
including methodological and clinically relevant quality
Table 1 Basic Characteristics of the Two Laboratory Databases
in Denmark
LABKA RLRR
Geographical Coverage and
Start of Data Collection
North Denmark region 1997 October 2013
Central Denmark region 2000 November 2013
Region of Southern Denmark – July 2015
Region of Zealand – October 2013
Capital region of Denmark – October 2014
Key Variables
Patient identification number + +
Sampling hour and minute + +
NPU or Danish modified code + +
Biomarker name + –
Laboratory ID Incomplete +
Requisitioner ID Incomplete +
Numeric results + +
Text-written results + “positive”, “negative”,
“ABO+RhD blood types”
Units + +
Reference limits/cut-offs + +
Abbreviations: LABKA, Clinical Laboratory Information System Research
Database at Aarhus University; NPU, Nomenclature, Properties, and Units; RhD,
Rhesus D blood type; RLRR, Register of Laboratory Results for Research.
Dovepress Arendt et al
Clinical Epidemiology 2020:12 submit your manuscript | www.dovepress.com
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criteria such as detection limits, variation of analyses over
time and across hospital laboratories, internal and external
quality assurance, electronic transfer of test results tomedical
files and databases, procedures for handling errors, and sys-
tematic assessment of these quality standards. The accredita-
tion status of an individual clinical laboratory can be found at
the website of the Danish Accreditation Fund.18
Data Resource Use
Use of routine biomarker data in epidemiological research
has tremendous potential, especially with linkage to other
Danish healthcare registries. By using the CPR number,
biomarker data can be linked with healthcare data at the
individual level, such as hospital diagnosis, redeemed pre-
scriptions and causes of death. We refer to other publica-
tions for descriptions of available resources of Danish
healthcare data.1–4 Biomarker data provide detailed infor-
mation about pathophysiological processes in individual
patients and add significant value to the comprehensive
network of Danish healthcare registries. In addition, the
laboratory databases also allow identification of specific
patients groups that are not readily captured by other data
sources in Denmark1 eg patients diagnosed and treated in
general practice. Below, we provide some study examples,
where biomarker data have been used. Since RLRR data
only recently became available, the studies were based on
data from the LABKA database.
Validation of registry data is fundamental to all types of
epidemiological research. Biomarker data are a key
resource for validating registry discharge diagnoses defined
by biomarkers, such as anaemia, electrolyte disorders, lipid
disorders, or diabetes.19 One such study examined the sen-
sitivity of hyponatraemia diagnoses in the Danish National
Patient Registry (DNPR).20 Only 2% of patients with
a record of low sodium levels in the LABKA database had
a hyponatraemia discharge diagnosis in the DNPR. The
study thus revealed the incompleteness of hyponatraemia
diagnoses in the DNPR. Laboratory data also can be used to
evaluate measures of prevalence and incidence of diseases,
risk factors for diseases, and the prognosis following abnor-
mal laboratory test results among patients that are recorded
with specific tests. As an example, a series of three studies
examined the risk of elevated potassium levels, associated
risk factors, and prognosis following hyperkalaemia in
patients with diabetes, heart failure, and chronic kidney
disease.21–23 The uniqueness of these large population-
based studies was their ability to separately appraise the
risk of mild, moderate, and severe elevation of plasma
potassium levels and to assess the risk of hyperkalaemia
as a function of glycaemic control (HbA1c) and kidney
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
RDW
HDL cholesterol
Triglycerides
MCV
Total cholesterol
Urea
Total bilirubin
TSH
EVF
HbA1c
Alkaline phosphatase
Albumin
Platelet count
C-reactive protein
ALAT
WBC count
Hemoglobin
Sodium
Potassium
Creatinine
Millions
Number of analyses
Number of unique IDs
Figure 1 Number of test results and unique personal identification (CPR) numbers of the 20 most frequent laboratory tests performed in the Central Denmark region,
2008–2018.
Abbreviations: ALAT, alanine aminotransferase; EVF, erythrocyte volume fraction; HDL, high-density lipoprotein; MCV, mean corpuscular volume; RDW, red blood cell
distribution width; TSH, thyroid stimulating hormone; WBC, white blood count.
Arendt et al Dovepress
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function (eGFR). In another series of studies, the associa-
tion between vitamin B12 levels and cancer was
evaluated.24–26 Not only was elevated vitamin B12 levels
a marker of occult cancer, it was also associated with poor
cancer prognosis and with the risk of venous thromboem-
bolism among cancer patients. Finally, laboratory data can
be used to assess the risk of specific drug side effects.
A recent study found that the risk of hyponatraemia was
higher among users of several different types of antidepres-
sant drugs compared to non-users.27
Strengths and Weaknesses
LABKA and the RLRR are valuable data resources for
research. Their geographical and temporal completeness is
relatively high, although the completeness varies between
the data sources (Table 1). They provide population-based
data encompassing most routine biomarker results from
Danish hospital laboratories. Another strength of the data-
bases stems from standardised quality assurance measures
implemented in most Danish hospital laboratories. These
standards ensure that erroneous test results caused by
interferences, such as haemolysis in the blood tube, endo-
genous proteins in a patient’s blood, or prescribed medical
drugs are systematically detected and expunged so they are
not provided to the clinician and not included in the
databases. Unambiguous individual-level data linkage
among the laboratory databases and other Danish health-
care registries ensures virtually endless opportunities for
conducting epidemiological research.
Use of routine laboratory data for research purposes
also has some potential limitations. Differences across
laboratories in analytical methods and laboratory equip-
ment imply that they do not necessarily produce compar-
able results and reference ranges for a given biomarker.
Moreover, individual laboratories occasionally change
their analytical methods, equipment, or units of measure-
ment. Thus, biomarker levels and reference ranges may
change over time within a given laboratory. However, the
generally high number of observations makes it possible to
account for such changes in most analyses. For example,
analyses can be stratified by time period or one can com-
bine data from laboratories with comparable analytic
methods and reference intervals. Another concern is that
the indications for specific requested biomarkers and the
reasons for repeated measurements are not readily avail-
able. It is beyond the scope of this Data Resource Profile
to assess regional differences or temporal changes in the
pattern of biomarker results.
Comparison with Other Biomarker
Data Sources
Other data sources that include biomarkers have been
described in several publications.28–32 They differ in sev-
eral ways from the data sources described here. Some use
the laboratory information systems to sample patients with
results of specific markers, such as plasma creatinin28,29
differential blood cell counts,30 or thyroid-stimulating
hormone.31 Hence, they are less comprehensive than the
resources presented here. Others have used data directly
from the laboratory information systems to assess research
hypothesis.32 This allows for more detailed information on
eg specimen handling, but data directly from the labora-
tory information systems are limited to smaller geographi-
cal areas of Denmark.
Other data sources include biomarker results only from
general practice, such as the UK-based General Practice
Research Database33 and The Health Improvement
Network.34
Data Resource Access
Researchers interested in using data from the LABKA data-
base could contact the Department of Clinical Epidemiology,
Aarhus University Hospital, Denmark, regarding specific
research projects.
The Danish Health Data Authority allows only Danish
institutions to access its data, subsequent to approval of
a formal application. The application must include the
background and purpose of the study, and a description
of the data sources and variables needed. Individual study
data are available to researchers who successfully com-
plete the application process, but they must access the data
through servers behind firewalls. Transfer of individual-
level data outside these servers is prohibited. Uploading of
external data to the servers is possible. The Danish Health
Data Authority ensures anonymization on their servers,
and any access to non-anonymized data requires additional
special approval. Access to registry data in Denmark for
research purposes does not require approval from an ethics
committee according to Danish law, but all studies should
be approved by the Danish Data Protection Agency.35
Foreign researchers can access data only through colla-
boration with a Danish institution that is approved for
handling and accessing data on the servers of the Danish
Health Data Authority. A fee for administration and data
access is charged for projects that achieve approval with
the Danish Health Data Authority.
Dovepress Arendt et al
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